Sign In
28 Dec 2011 07:00
RNS Number : 6517U
Phorm Inc
28 December 2011
Β
ο»Ώ
28 December 2011
Phorm, Inc. ("Phorm" or the "Company")
Director Dealing
Β
Phorm (AIM: PHRM and PHRX) announces that on December 28th Kent Ertugrul, CEO and Chairman of the Company, transferred for nil consideration 2,594,412 shares in the Company to Value Trust Holdings Pte Ltd limited for tax planning purposes.
Β
For Enquiries
Β
Phorm, Inc.
Andy Croxson (analysts & investors) +44 20 7297 2326
Alex Laity (media) +44 20 7297 2710
Β
Canaccord Genuity Limited +44 20 7050 6500
(Nominated Advisor)
Simon Bridges, Andrew Chubb
This information is provided by RNS
The company news service from the London Stock Exchange
Β
ENDΒ
Β
RDSBVLBLFLFBFBZ
PHRM.L (PHRM)
Follow the stocks
